Early onset of ageing and rising adoption of lesser painful minimally invasive or non-surgical rejuvenation procedures are major factors driving the growth of the global facial rejuvenation market currently. Other trends driving the market growth include easier access to treatments, rising affordability, increasing awareness about more innovative and less painful procedures, deeper penetration of beauty products in the local markets, and demand for quicker results and shorter treatment duration by patients. However, the market is expected to witness regulatory overhaul with an increase in procedure and product standardization during the forecast period (2015–2021).
Browse Complete Report @ http://www.persistencemarketresearch.com/market-research/facial-rejuvenation-market.asp
The absence of standardized regulations is leading to an influx of many local players in both the developed and emerging regions. Furthermore, lack of documented and approved product efficacy is also hampering the growth of this market. Major players dominate the market in developed regions currently. Local players offer similar local products at 20% – 30% price discounts compared to that offered by renowned and established companies in North America and Europe. This leads to unhealthy competition and could also hamper patient safety.
The global facial rejuvenation market is expected to expand at a CAGR of 4.9% during the forecast period 2015-2021.
This report assesses trends driving each market segment and offers analysis and insights about the potential of facial rejuvenation therapies in specific regions. North America is estimated to dominate the facial rejuvenation market with the maximum value share of the overall market by the end of 2015. By 2021, North America and Europe markets are expected to account for over three-fifth share of the global facial rejuvenation market revenue. In terms of value, North America is estimated to be the dominant market, registering a CAGR of 7.4% over the forecast period.
The global facial rejuvenation market has been segmented into five major regions, namely North America, Latin America, Europe, Asia-Pacific and the Middle East & Africa. In terms of value, North America is estimated to dominate the market, accounting for over a third of the overall market by 2015 end. Latin America and Asia Pacific are estimated to be the fastest-growing emerging markets. Currently, botulinum products are a major revenue contributor in most regions. Among dermal fillers, the hyaluronic acid based fillers used for volume restoration are more preferred over other types. Growing popularity of combination treatments and their rising adoption among customers is expected to boost revenue growth of the facial rejuvenation market in the coming years.
Download Report Sample @ http://www.persistencemarketresearch.com/samples/3639
Some of the key players identified in the global facial rejuvenation drug market report include Merz GmbH & Co. KGaA, LUMENIS, Revance Therapeutics, Inc., Biopolymer GmbH &Co KG, Speciality European Pharma, Mentor Worldwide LLC, Anika Therapeutics, Inc., Contura International A/S, Cynosure, Inc., Fibrocell, Inc., and Gal derma S/A. The report is enriched through identification of company-specific strategies related to drug development, market consolidation initiatives, and analyses of the various market player’s specific strengths, weaknesses, opportunities, and threats.
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353